Catto A, Rossi A, Leonardi A, Testa R, Nardi D
Research Division, Recordati S.P.A., Milano.
Farmaco. 1989 Jun;44(6):595-607.
A number of new 1,2-diphenylethane derivatives were synthesized and tested for anticonvulsant activity. Their structure was designed on the basis of the potential metabolic degradation of the imidazole ring present in denzimol ( ( +/- )-N-[2-[4-(beta-phenylethyl)phenyl]-2-hydroxethyl]imidazole), a potent anticonvulsant. The compounds which inhibited the electroshock-induced seizures (MES) in mice, namely N-[4-(beta-phenylethyl)phenacyl]formamide (VII) and N-[2-[4-(beta-phenylethyl)phenyl]-2-hydroxyethyl]formamide (IX), proved active also as inhibitors of the pentylenetetrazole-induced tonic seizures. The results of the pharmacological screening were evaluated in relation to the lipophilicity of the compounds.
合成了多种新型1,2 - 二苯乙烷衍生物,并对其抗惊厥活性进行了测试。它们的结构是基于强效抗惊厥药登齐莫尔((±)-N-[2-[4-(β-苯乙基)phenyl]-2-羟乙基]咪唑)中咪唑环的潜在代谢降解而设计的。抑制小鼠电休克诱导惊厥(MES)的化合物,即N-[4-(β-苯乙基)苯甲酰基]甲酰胺(VII)和N-[2-[4-(β-苯乙基)phenyl]-2-羟乙基]甲酰胺(IX),也被证明是戊四氮诱导的强直性惊厥的有效抑制剂。根据化合物的亲脂性对药理筛选结果进行了评估。